Harvard Bioscience, Inc. Overview
Pro stress-test →Harvard Bioscience is a global developer, manufacturer and marketer of life sciences equipment to support research and drug discovery. The company develops, manufactures and sells technologies, products and services used in research, drug and therapy discovery, bio-production and preclinical testing.
Strategic Profile
Pro stress-test →The company's product portfolio is broken into five market segments: Fluidics, Laboratory Equipment & Supplies, Molecular Analysis, Cell Analysis, and Physiology. In summer 2025 the board was reconstituted with a new CEO appointed, and in December 2025 the company successfully refinanced its debt, obtaining a $40 million credit facility with BroadOak Capital.
Competitive Landscape
Pro stress-test →Harvard Bioscience operates in the life sciences equipment and instrumentation market, competing against larger diversified life sciences companies and specialized equipment manufacturers. The company differentiates through proprietary platforms in cellular and molecular analysis, physiology monitoring, and electrophysiology, serving academic institutions, pharmaceutical companies, and biotech firms globally.
Industry Context
Harvard Bioscience, Inc. operates in Life Sciences Equipment & Instrumentation / Biotech Research Tools.
Key facts
Founded: 1901 · Headquarters: Holliston, MA, United States · Employees: 343 · Revenue: $85-90M · Market cap: $26-35M